Welcome to the 3rd TCR-based Therapies for Solid Tumors Summit Advancing Engineered, Native & Bispecific TCRs to Effectively Treat Solid Tumors Do you want to gain unrivalled industry knowledge to build a first-class TCR-based therapy with high efficacy and targeting power in solid tumors? The industry-leading TCR-based Therapies for Solid Tumors S
27-29 June 2022